NEW YORK (GenomeWeb News) – NanoString Technologies said today that it is collaborating with the Broad Institute of MIT and Harvard to investigate molecular networks involved in immune response and other biological processes.

As part of the collaboration, NanoString and Broad will also explore potential new basic and clinical research applications for NanoString's digital gene expression technology, NanoString said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.